Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

cardlytics inc - CDLX

CDLX

Close Chg Chg %
1.43 0.09 6.29%

Pre-Market

1.52

+0.09 (6.29%)

Volume: 890.33K

Last Updated:

Jan 8, 2026, 4:00 PM EDT

Trade Now

Company Overview: cardlytics inc - CDLX

CDLX Key Data

Open

$1.43

 Day Range

1.40 - 1.54

52 Week Range

0.85 - 4.05

 Market Cap

$70.81M

Shares Outstanding

54.06M

 Public Float

51.31M

Beta

1.07

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$2.10

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

884.15K

  

CDLX Performance

1 Week
 
 32.17%
 
1 Month
 
 40.74%
 
3 Months
 
 -20.42%
 
1 Year
 
 -51.44%
 
5 Years
 
 -98.97%
 

CDLX Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 4
Full Ratings ➔

About cardlytics inc - CDLX

Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

CDLX At a Glance

Cardlytics, Inc.
675 Ponce de Leon Avenue NE
Atlanta, Georgia 30308
Phone 1-888-798-5802 Revenue 278.30M
Industry Internet Software/Services Net Income -189,304,000.00
Sector Technology Services Employees 454
Fiscal Year-end 12 / 2025
View SEC Filings

CDLX Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.645
Price to Book Ratio 2.717
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -9.408
Enterprise Value to Sales 1.205
Total Debt to Enterprise Value 0.661

CDLX Efficiency

Revenue/Employee 612,991.189
Income Per Employee -416,969.163
Receivables Turnover 2.60
Total Asset Turnover 0.576

CDLX Liquidity

Current Ratio 1.195
Quick Ratio 1.195
Cash Ratio 0.44

CDLX Profitability

Gross Margin 44.861
Operating Margin -22.829
Pretax Margin -68.022
Net Margin -68.022
Return on Assets -39.159
Return on Equity -184.875
Return on Total Capital -64.909
Return on Invested Capital -58.925

CDLX Capital Structure

Total Debt to Total Equity 316.676
Total Debt to Total Capital 76.001
Total Debt to Total Assets 56.441
Long-Term Debt to Equity 248.258
Long-Term Debt to Total Capital 59.581
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Cardlytics Inc - CDLX

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
267.12M 298.54M 309.20M 278.30M
Sales Growth
+42.93% +11.76% +3.57% -10.00%
Cost of Goods Sold (COGS) incl D&A
171.14M 193.05M 177.04M 153.45M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
33.66M 43.74M 29.52M 27.88M
Depreciation
- - 6.70M 11.60M
-
Amortization of Intangibles
- - 23.17M 32.14M
-
COGS Growth
+46.11% +12.80% -8.29% -13.32%
Gross Income
95.97M 105.49M 132.17M 124.85M
Gross Income Growth
+37.58% +9.92% +25.29% -5.54%
Gross Profit Margin
+35.93% +35.34% +42.74% +44.86%
2021 2022 2023 2024 5-year trend
SG&A Expense
192.82M 241.03M 195.84M 188.38M
Research & Development
38.10M 54.44M 51.35M 49.61M
Other SG&A
154.72M 186.59M 144.48M 138.77M
SGA Growth
+55.91% +25.00% -18.75% -3.81%
Other Operating Expense
- - - -
-
Unusual Expense
25.75M 322.24M 65.45M 118.95M
EBIT after Unusual Expense
(122.60M) (457.78M) (129.12M) (182.48M)
Non Operating Income/Expense
(970.00K) (4.94M) 601.00K 2.08M
Non-Operating Interest Income
297.00K 1.44M 3.85M 3.35M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
12.86M 3.99M 6.18M 8.90M
Interest Expense Growth
+268.69% -68.94% +54.81% +43.99%
Gross Interest Expense
12.86M 3.99M 6.18M 8.90M
Interest Capitalized
- - - -
-
Pretax Income
(136.43M) (466.71M) (134.70M) (189.30M)
Pretax Income Growth
-146.16% -242.09% +71.14% -40.54%
Pretax Margin
-51.07% -156.33% -43.56% -68.02%
Income Tax
- - (7.86M) (1.45M)
-
Income Tax - Current - Domestic
596.00K 587.00K (11.53M) (14.34M)
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(6.28M) 1.04M 10.57M 11.22M
Income Tax - Deferred - Foreign
(2.18M) (3.08M) 961.00K 3.12M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(128.56M) (465.26M) (134.70M) (189.30M)
Minority Interest Expense
- - - -
-
Net Income
(128.56M) (465.26M) (134.70M) (189.30M)
Net Income Growth
-131.97% -261.89% +71.05% -40.54%
Net Margin Growth
-48.13% -155.85% -43.56% -68.02%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(128.56M) (465.26M) (134.70M) (189.30M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(128.56M) (465.26M) (134.70M) (189.30M)
EPS (Basic)
-3.9924 -13.9221 -3.6917 -3.9144
EPS (Basic) Growth
-96.03% -248.72% +73.48% -6.03%
Basic Shares Outstanding
32.20M 33.42M 36.49M 48.36M
EPS (Diluted)
-3.9924 -13.9221 -3.6917 -3.9144
EPS (Diluted) Growth
-96.03% -248.72% +73.48% -6.03%
Diluted Shares Outstanding
32.20M 33.42M 36.49M 48.36M
EBITDA
(63.20M) (91.80M) (34.15M) (35.66M)
EBITDA Growth
-52.29% -45.26% +62.79% -4.40%
EBITDA Margin
-23.66% -30.75% -11.05% -12.81%

Snapshot

Average Recommendation HOLD Average Target Price 1.625
Number of Ratings 4 Current Quarters Estimate -0.263
FY Report Date 03 / 2026 Current Year's Estimate -0.837
Last Quarter’s Earnings -0.21 Median PE on CY Estimate N/A
Year Ago Earnings -2.007 Next Fiscal Year Estimate N/A
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 3 N/A
Mean Estimate -0.26 -0.21 -0.84 N/A
High Estimates -0.23 -0.18 -0.67 N/A
Low Estimate -0.33 -0.28 -1.09 N/A
Coefficient of Variance -21.92 -27.06 -26.65 N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 0 0 0
OVERWEIGHT 0 0 0
HOLD 3 3 4
UNDERWEIGHT 1 1 1
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Cardlytics Inc - CDLX

Date Name Shares Transaction Value
May 21, 2025 Scott Anthony Hill Director 11,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2025 Andre John Fernandez Director 11,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2025 Liane Hornsey Director 11,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2025 Jon Francis Director 11,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2025 John L. Klinck Director 11,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2025 Srishti Gupta Director 11,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Alexis DeSieno Chief Financial Officer 57,398 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Alexis DeSieno Chief Financial Officer 147,300 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $1.81 per share 266,613.00
Apr 4, 2025 Alexis DeSieno Chief Financial Officer 155,298 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Amit Gupta Chief Executive Officer; Director 57,398 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Amit Gupta Chief Executive Officer; Director 371,080 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $1.81 per share 671,654.80
Apr 4, 2025 Amit Gupta Chief Executive Officer; Director 378,422 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Nicholas Lynton Chief Legal & Privacy Officer 7,890 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Nicholas Lynton Chief Legal & Privacy Officer 2,325 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Nicholas Lynton Chief Legal & Privacy Officer 42,518 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Nicholas Lynton Chief Legal & Privacy Officer 101,740 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $1.81 per share 184,149.40
Apr 4, 2025 Nicholas Lynton Chief Legal & Privacy Officer 107,494 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Nicholas Lynton Chief Legal & Privacy Officer 105,916 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Nicholas Lynton Chief Legal & Privacy Officer 105,335 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 20, 2025 Amit Gupta Chief Executive Officer; Director 364,072 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $3.18 per share 1,157,748.96

Cardlytics Inc in the News